Maintaining blood-sugar levels protects from eye, kidney illness in diabetes patients
NEW YORK New data published last week in the journal Diabetes Care suggests that control of blood-sugar levels over an extended period of time may help reduce the risk of diabetes-related eye and kidney disease for people with Type 1 diabetes.
The findings come out of the Diabetes and Control and Complications Trial, which tracked 1,441 Type 1 diabetic patients over nine years.
Specifically, for every 1 percent increase in hemoglobin A1C, researchers found that both the risk of retinopathy and the risk of diabetic kidney disease more than doubled, respectively.
King announces acquisition of Alpharma
BRISTOL, Tenn. King Pharmaceuticals will acquire Alpharma in a deal worth $1.6 billion, King said Monday.
Alpharma had rejected a $33-per-share bid King made earlier, but accepted the most recent $37-per-share bid.
Alpharma, based in Bridgewater, N.J., has lately sought regulatory approval for painkillers designed to thwart abuse, such as Remoxy, a liquid capsule-based formulation of oxycodone.
Viagra under investigation for effect on athletes
NEW YORK The World Anti-Doping Agency is investigating whether the drug Viagra gives athletes a competitive advantage on the playing field.
The drug, known generically as sildenafil citrate and made by Pfizer, works by opening the blood vessels. According to published reports, some experts have said this could give athletes more endurance by increasing the bloodstreams ability to deliver oxygen.
If studies indicate that Viagra does give athletes an advantage, WADA will consider listing it as a performance-enhancing drug.